France Services, news and resources from France Tweet Jump to ServicesNewsNews in other languagesLibrary resources Showing 28 services Show as list Actif-Santé Town/City Paris AFEF - Association Française pour l'Etude du Foie Société Française d'Hépatologie Town/City Paris AFR Town/City Pantin ANRS (France REcherche Nord & Sud Sida-HIV et Hépatites) Town/City Paris ARAVIH Association Réseau Annécien Ville Hôpital Autour du VIH & des Hépatites Town/City Annecy ASUD Autosupport des Usagers et Ex-Usagers de Drogues Town/City Paris ASUD Loiret Town/City Orléans ASUD Marseille Town/City Marseille ASUD Nîmes Town/City Nîmes AVHEC - Association Ville Hôpital Hépatite C La Maison du Patient Town/City Lyon CHU de Poitiers - Pôle de référence pour les hépatites virales Town/City Poitiers Collectif Hépatites Virales Town/City Bagnolet Fédération Addiction Town/City Paris Fédération Nationale des Pôles de Référence et Réseaux Hépatites Town/City Paris Hépatites Info Service SIS Association Town/City Ivry-sur-Seine Hepsilo - Réseau Ville Hôpital Hépatites Sida Loiret Town/City Orléans L'ADIS - Association pour le Développement des Initiatives contre le Sida et l'hépatite C Town/City Dunkerque Le Trait d'Union Centre de Soins de l'Infection par le VIH Town/City Strasbourg Prométhée Alpes Réseau Town/City Grenoble Réseau Hépatites Haute-Normandie Town/City Rouen Réseau Hépatites Languedoc Roussillon Town/City Montpellier Réseau Hépatites Virales Basse-Normandie Town/City Caen Réseau ville hopital Hépatite C Côte d’Azur Secretariat Town/City Nice Réseau Ville-Hôpital 93 Centre Town/City Aubervilliers Réseau Ville-Hôpital VIH-Hépatites Maladies Infectieuses et Tropicales Town/City Nantes REVIH 86 - Réseau Ville Hôpital VIH/VHC 86 Town/City Poitiers Société d'Hépato-Gastroentérologie de Catalogne-Roussillon Centre Catalan des Hépatites Town/City Perpignan SOS Hépatites Fédération Town/City Bagnolet News Hepatocellular carcinoma (HCC) Models can help predict liver cancer in people cured of hepatitis C Liz Highleyman / 17 September 2020 Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving sustained virological response to hepatitis C treatment, according to studies presented at the recent 2020 Digital ... Treatment for people living with HIV and HCV People with HIV do not have higher liver disease risk after hepatitis C treatment Keith Alcorn / 28 August 2020 People living with HIV do not have a higher risk of liver-related complications or death from liver disease after hepatitis C treatment with direct-acting antivirals, researchers from the French HEPAVIH cohort reported this ... Coronavirus Non-alcoholic fatty liver disease does not raise the risk of COVID-19, gene study shows Keith Alcorn / 26 May 2020 People with a genetic profile that strongly predicts non-alcoholic or metabolic-associated fatty liver disease were not at higher risk of being hospitalised with COVID-19 in the United Kingdom, an analysis of the ... Treatment in acute infection Short-course treatment for recent hepatitis C: some courses may be too short Keith Alcorn / 07 May 2020 An eight-week course of grazoprevir/elbasvir (Zepatier) achieved a high cure rate in people recently infected with hepatitis C, but another study found that a six-week course of sofosbuvir/velpatasvir (Epclusa) resulted in an inferior ... NAFLD Fatty liver raises the risk of death in people with HIV and hepatitis C Keith Alcorn / 15 September 2019 People with HIV and hepatitis C co-infection who had fatty liver disease were twice as likely to die during a five-year follow-up period as their counterparts without fatty liver disease, ... More news News in other languages Canada: Les lignes directrices canadiennes sur la co-infection VIH-VHC arrivent bientôt CATIE / 17 December 2013 Sofosbuvir: De nouvelles associations interpellent Gilead Seronet / 16 December 2013 France: Percée thérapeutique contre l'hépatite C Le Figaro / 11 December 2013 Gilead Sciences, Inc. : L'agence américaine des médicaments (U.S. Food and Drug Administration) approuve le Sovaldi? (sofosbuvir) de Gilead pour le traitement de l'hépatite C chronique Zone Bourse / 10 December 2013 France: VHB et VHC : Journée nationale des patients le 14 décembre Seronet / 10 December 2013 More Library resources Technical supplement - The new psychoactive products Type.pdf Published19 March 2014 Posted byFédération Addiction How to reduce risks with the new psychoactive substances (NPS) Type.pdf Published19 March 2014 Posted byFédération Addiction Prise de position de la SPILF, l’AFEF, la SFLS et la SNFMI sur l’utilisation des inhibiteurs de protéase de 1ere génération du VHC chez les patients co-infectés par le VIH et le VHC de génotype 1 TypeWeb page Published22 March 2013 AuthorSNSMI, SFLS, AFEF, et SPILF AVIS relatif à la vaccination contre la grippe saisonnière chez les personnes atteintes d’une hépatopathie chronique avec ou sans cirrhose TypeWeb page Published22 February 2013 AuthorHaut Conseil de la santé publique View more resources Do you work for a hepatitis organisation?Add your organisation to the listings > World Hepatitis Alliance policy report on the prevention and control of viral hepatitis Download the report for France To see all of the World Hepatitis Alliance Global Policy Reports, please visit the WHA website. ELPA’s Euro Hepatitis Care Index Download Indicators for France on prevention; screening; access to treatment; national strategy; outcomes. To see all of the European Care Index and compare indicators between counties please visit: www.hep-index.eu/index-map.html.